AU6330300A - Use of interleukin-6 in treatment of obesity and/or obesity associated disorders - Google Patents

Use of interleukin-6 in treatment of obesity and/or obesity associated disorders

Info

Publication number: AU6330300A
Authority: AU; Australia
Prior art keywords: obesity; interleukin; treatment; associated disorders; obesity associated
Prior art date: 1999-07-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU63303/00A

Inventor

John-Olov Jansson

Ville Wallenius

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sahltech i Goteborg AB

Original Assignee

Sahltech i Goteborg AB

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-13

Filing date

2000-07-13

Publication date

2001-01-30

1999-07-13 Priority claimed from SE9902680A external-priority patent/SE9902680D0/en

2000-07-13 Application filed by Sahltech i Goteborg AB filed Critical Sahltech i Goteborg AB

2001-01-30 Publication of AU6330300A publication Critical patent/AU6330300A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2264—Obesity-gene products, e.g. leptin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Obesity (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Zoology (AREA)
Diabetes (AREA)
Hematology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Child & Adolescent Psychology (AREA)
Genetics & Genomics (AREA)
Endocrinology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU63303/00A 1999-07-13 2000-07-13 Use of interleukin-6 in treatment of obesity and/or obesity associated disorders Abandoned AU6330300A (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
SE9902680A SE9902680D0 (en)	1999-07-13	1999-07-13	Use of interleukin-6 in the treatment of obesity and disorders of blood fats
SE9902680		1999-07-13
SE9904424A SE9904424D0 (en)	1999-07-13	1999-12-03	Use of interleukin-6 in combination with leptin in the treatment of obesity
SE9904424		1999-12-03
PCT/SE2000/001491 WO2001003725A1 (en)	1999-07-13	2000-07-13	Use of interleukin-6 in treatment of obesity and/or obesity associated disorders

Publications (1)

Publication Number	Publication Date
AU6330300A true AU6330300A (en)	2001-01-30

Family

ID=26663620

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU63303/00A Abandoned AU6330300A (en)	1999-07-13	2000-07-13	Use of interleukin-6 in treatment of obesity and/or obesity associated disorders

Country Status (4)

Country	Link
EP (1)	EP1194159A1 (en)
AU (1)	AU6330300A (en)
SE (1)	SE9904424D0 (en)
WO (1)	WO2001003725A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030129160A1 (en) *	2002-01-09	2003-07-10	John-Olov Jansson	Use of Interleukin-6
SE0201689D0 (en) *	2002-06-03	2002-06-03	Sahltech Ab	A method for identifying obese IL-6 responsive patients
CN101219208B (en) *	2005-01-04	2010-08-11	健能隆医药技术（上海）有限公司	Medicine use of interleukin-22
FR3080533A1 (en)	2018-04-27	2019-11-01	Enterosys	USE OF IL-6 FOR THE TREATMENT OF DIABETES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH05186367A (en) *	1991-08-06	1993-07-27	Toray Ind Inc	Therapeutic agent for hyperlipemia
KR19990087392A (en) *	1996-03-01	1999-12-27	스티븐 엠. 오드레	Dog OB Protein Compositions and Methods

1999
- 1999-12-03 SE SE9904424A patent/SE9904424D0/en unknown
2000
- 2000-07-13 EP EP00950167A patent/EP1194159A1/en not_active Withdrawn
- 2000-07-13 WO PCT/SE2000/001491 patent/WO2001003725A1/en not_active Application Discontinuation
- 2000-07-13 AU AU63303/00A patent/AU6330300A/en not_active Abandoned

Also Published As

Publication number	Publication date
SE9904424D0 (en)	1999-12-03
WO2001003725A1 (en)	2001-01-18
EP1194159A1 (en)	2002-04-10

Similar Documents

Publication	Publication Date	Title
AU3725997A (en)	1998-02-10	S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
AU2001293553A1 (en)	2002-04-02	Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
IL187512A0 (en)	2008-06-05	Use of (s,s)-reboxetine in the treatment of pain conditions and incontinence
HUP0203367A3 (en)	2004-12-28	Benzylidine-thiazolidinediones and analogues and their use in the treatment of diabetes
AU6232899A (en)	2001-05-10	Use of transforming growth factor beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa
HUP0401023A3 (en)	2004-10-28	Use of flibanserin in the treatment of sexual disorders
AU2003291609A1 (en)	2004-07-29	Cb 1/cb 2 receptor ligands and their use in the treatment of pain
AU4171500A (en)	2000-10-23	Flupirtine in the treatment of fibromyalgia and related conditions
HUP0301122A3 (en)	2005-03-29	Pharmaceutical combinations and their use in treating gastrointestinal disorders
AU4340700A (en)	2000-11-14	Methods and compositions for use in the treatment of hyperlipidemia
AU7528001A (en)	2001-12-17	The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
AU2002252976A1 (en)	2002-09-19	Hydrazones and their therapeutic use
AU2003286285A1 (en)	2004-06-18	Use of fgf-18 in the diagnosis and treatment of memory disorders
AU3099997A (en)	1998-01-07	The use of tcet in the prophylaxis and treatment of allergies
ZA97741B (en)	1997-07-30	Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders.
MXPA02000779A (en)	2003-10-15	Highly purified cytokine activating factor and methods of use.
PL352333A1 (en)	2003-08-11	Dihydrobenzodiazepines and use of same in treatment of dislipidemia
IL160018A0 (en)	2004-06-20	Isoxazolopyridinones and use thereof in the treatment of parkinson's disease
GB0128674D0 (en)	2002-01-23	Treatment of sleep disorders and the like
AU2001251306A1 (en)	2001-10-15	Treatment of sleep disorders with hypocretin-1
AU6330300A (en)	2001-01-30	Use of interleukin-6 in treatment of obesity and/or obesity associated disorders
AU2529799A (en)	1999-08-23	Benzofuran-4-carboxamides and their therapeutic use
AU2003244455A1 (en)	2003-09-02	Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
AU2002210763A1 (en)	2002-05-15	Use of 1-ebio in the treatment of bipolar disorders
GB9903919D0 (en)	1999-04-14	Aminophenols and their therapeutic use

Legal Events

Date	Code	Title	Description
2002-04-18	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase